BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pasalic D, Betancourt-Cuellar SL, Taku N, Ludmir EB, Lu Y, Allen PK, Tang C, Antonoff MB, Fuller CD, Rosenthal DI, Morrison WH, Phan J, Garden AS, Welsh JW, Chang JY, Liao Z, Erasmus JJ, Nguyen QN. Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer. Head Neck 2020;42:1939-53. [PMID: 32129548 DOI: 10.1002/hed.26117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Cw. Wong K, Johnson D, Hui EP, Ct. Lam R, By. Ma B, Tc. Chan A. Opportunities and Challenges in Combining Immunotherapy and Radiotherapy in Head and Neck Cancers. Cancer Treatment Reviews 2022. [DOI: 10.1016/j.ctrv.2022.102361] [Reference Citation Analysis]
2 Xing DT, Khor R, Gan H, Wada M, Ermongkonchai T, Ng SP. Recent Research on Combination of Radiotherapy with Targeted Therapy or Immunotherapy in Head and Neck Squamous Cell Carcinoma: A Review for Radiation Oncologists. Cancers (Basel) 2021;13:5716. [PMID: 34830871 DOI: 10.3390/cancers13225716] [Reference Citation Analysis]
3 Borson S, Shuai Y, Branstetter BF, Nilsen ML, Hughes MA, Fenton M, Kubik M, Sridharan S, Clump DA, Skinner HD, Johnson JT, Chiosea SI, Ohr J, Duvvuri U, Kim S, Traylor KS, Ferris R, Zandberg DP. Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis. Laryngoscope Investig Oto. [DOI: 10.1002/lio2.807] [Reference Citation Analysis]
4 Franzese C, Badalamenti M, Teriaca A, De Virgilio A, Mercante G, Cavina R, Ferrari D, Santoro A, Spriano G, Scorsetti M. Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer. J Cancer Res Clin Oncol 2021;147:1307-13. [PMID: 33471186 DOI: 10.1007/s00432-021-03518-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Szturz P, Nevens D, Vermorken JB. Oligometastatic Disease Management: Finding the Sweet Spot. Front Oncol 2020;10:617793. [PMID: 33415080 DOI: 10.3389/fonc.2020.617793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shen Z, Tan X, Li S, Tian X, Luo H, Wang Y, Jin F. Correlation between the γ passing rates of IMRT plans and the volumes of air cavities and bony structures in head and neck cancer. Radiat Oncol 2021;16:134. [PMID: 34289863 DOI: 10.1186/s13014-021-01861-y] [Reference Citation Analysis]
7 Antonoff MB, Sofocleous CT, Callstrom MR, Nguyen QN. The roles of surgery, stereotactic radiation, and ablation for treatment of pulmonary metastases. J Thorac Cardiovasc Surg 2021:S0022-5223(21)00423-2. [PMID: 33838914 DOI: 10.1016/j.jtcvs.2021.01.143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Weissmann T, Höfler D, Hecht M, Semrau S, Haderlein M, Filimonova I, Frey B, Bert C, Lettmaier S, Mantsopoulos K, Iro H, Fietkau R, Putz F. Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites? Radiat Oncol 2021;16:62. [PMID: 33789725 DOI: 10.1186/s13014-021-01790-w] [Reference Citation Analysis]
9 Mat Lazim N, Elliott M, Wykes J, Clark J. Oligometastases in head and neck carcinoma and their impact on management. ANZ J Surg 2021. [PMID: 33634950 DOI: 10.1111/ans.16622] [Reference Citation Analysis]
10 Wise-Draper TM, Bahig H, Karivedu V, Burtness B. Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges. Am Soc Clin Oncol Educ Book 2022;42:1-14. [PMID: 35486888 DOI: 10.1200/EDBK_350442] [Reference Citation Analysis]
11 Yang W, Mei X, Zhou Y, Su R, Lei W, Zheng S, Zhu R, Guo L, Tao Y, Su Y, Li J, Ding C, Zou S, Li X, Hu H. Risk factors and survival outcomes of laryngeal squamous cell carcinoma patients with lung metastasis: A population-based study. Auris Nasus Larynx 2021;48:723-30. [PMID: 33358379 DOI: 10.1016/j.anl.2020.11.009] [Reference Citation Analysis]
12 Oliveira TB, Mesía R, Falco A, Hsieh JC, Yokota T, Saada-Bouzid E, Schmitz S, Elicin O, Giacomelli L, Bossi P. Defining the needs of patients with recurrent and/or metastatic head and neck cancer: An expert opinion. Crit Rev Oncol Hematol 2021;157:103200. [PMID: 33321152 DOI: 10.1016/j.critrevonc.2020.103200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Vincent AG, Wang W, Shokri T, Ducic Y. Treatment of Oligometastatic Disease in Squamous Cell Carcinoma of the Head and Neck. Laryngoscope 2021;131:E1476-80. [PMID: 33044014 DOI: 10.1002/lary.29115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]